DHP-218

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDHP-218
Drug Alias NamePAK-9DHP-218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Shinyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A